lysine has been researched along with Atrial Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocian, K; Fiszer, U; Korczak-Kowalska, G; Leńska-Mieciek, M | 1 |
| Begieneman, MP; Krijnen, PA; Kubat, B; Niessen, HW; Paulus, WJ; Rijvers, L; Schalkwijk, CG; Stooker, W; van Rossum, AC; Vonk, AB | 1 |
2 other study(ies) available for lysine and Atrial Fibrillation
| Article | Year |
|---|---|
Pentosidine, advanced glycation end product, in acute ischaemic stroke patients with and without atrial rhythm disturbances.
Topics: Arginine; Atrial Fibrillation; Brain Ischemia; Carotid Intima-Media Thickness; Humans; Lysine; Risk Factors; Stroke | 2020 |
Atrial fibrillation coincides with the advanced glycation end product N(ε)-(carboxymethyl)lysine in the atrium.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Fibrosis; Granulocytes; Heart Atria; Humans; Lymphocytes; Lysine; Macrophages; Male; Middle Aged; Myocardium; Vascular Cell Adhesion Molecule-1 | 2015 |